Clinical Trials Logo

Clinical Trial Summary

This is A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison with Imipenem/Cilastatin/Relebactam in Adults with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05204563
Study type Interventional
Source Sinovent Pty Ltd.
Contact
Status Not yet recruiting
Phase Phase 3
Start date March 2022
Completion date December 2024